Logo image of PSTH

Pershing Square Tontine Holdings Ltd (PSTH) Stock Fundamental Analysis

NYSE:PSTH - New York Stock Exchange, Inc. - US71531R1095 - Common Stock - Currency: USD

20.14  +0.01 (+0.05%)

After market: 20.14 0 (0%)

Fundamental Rating

2

PSTH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. No worries on liquidiy or solvency for PSTH as it has an excellent financial health rating, but there are worries on the profitability. PSTH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSTH was profitable.
PSTH Yearly Net Income VS EBIT VS OCF VS FCFPSTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 500M -500M

1.2 Ratios

Industry RankSector Rank
ROA 11.86%
ROE 12.81%
ROIC -0.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTH Yearly ROA, ROE, ROICPSTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 10 -10 20 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTH Yearly Profit, Operating, Gross MarginsPSTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PSTH is destroying value.
Compared to 1 year ago, PSTH has about the same amount of shares outstanding.
PSTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PSTH Yearly Shares OutstandingPSTH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 50M 100M 150M
PSTH Yearly Total Debt VS Total AssetsPSTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 8.44 indicates that PSTH is not in any danger for bankruptcy at the moment.
There is no outstanding debt for PSTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.44
ROIC/WACC0
WACC8.71%
PSTH Yearly LT Debt VS Equity VS FCFPSTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 1B 2B 3B

2.3 Liquidity

PSTH has a Current Ratio of 12.25. This indicates that PSTH is financially healthy and has no problem in meeting its short term obligations.
PSTH has a Quick Ratio of 12.25. This indicates that PSTH is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 12.25
Quick Ratio 12.25
PSTH Yearly Current Assets VS Current LiabilitesPSTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 174.76% over the past year.
EPS 1Y (TTM)174.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PSTH Yearly Revenue VS EstimatesPSTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021
PSTH Yearly EPS VS EstimatesPSTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.72, which indicates a very decent valuation of PSTH.
PSTH is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.72
Fwd PE N/A
PSTH Price Earnings VS Forward Price EarningsPSTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTH Per share dataPSTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PSTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Pershing Square Tontine Holdings Ltd

NYSE:PSTH (7/25/2022, 8:17:24 PM)

After market: 20.14 0 (0%)

20.14

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change85.21%
Ins Owners0%
Ins Owner Change0%
Market Cap4.03B
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.72
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.31
EY11.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS18.65
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.86%
ROE 12.81%
ROCE N/A
ROIC -0.03%
ROICexc N/A
ROICexgc -0.03%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.25
Quick Ratio 12.25
Altman-Z 8.44
F-Score5
WACC8.71%
ROIC/WACC0
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)174.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A